Table: RaQualia Pharma - 9-MTH group results

RaQualia Pharma

14/11/2025 06:37

Nov 14 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to  
                Sep 30, 2025        Sep 30, 2024      Dec 31, 2025 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales             2.31                2.37              3.89     
                 (-2.5 pct)          (+58.4 pct)      (+25.1 pct)  
  Operating     loss 344 mln         loss 27 mln        118 mln    
  Recurring     loss 426 mln        loss 231 mln         73 mln    
  Net           loss 568 mln        loss 339 mln      loss 71 mln  
  EPS          loss 24.29 yen      loss 15.71 yen    loss 3.25 yen 
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T